Massachusetts Financial Services CO Spring Works Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

$314 Billion
Q2 2024

A detailed history of Massachusetts Financial Services CO transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 535,083 shares of SWTX stock, worth $17.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

535,083

Previous 465,856 14.86%

Holding current value

$17.1 Million

Previous $22.9 Million 12.09%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$36.06 - $47.62 $2.5 Million - $3.3 Million	69,227 Added 14.86%	535,083 $20.2 Million
Q1 2024 May 14, 2024	SELL	$36.5 - $52.5 $81,103 - $116,655	-2,222 Reduced 0.47%	465,856 $22.9 Million
Q4 2023 Feb 08, 2024	BUY	$18.94 - $37.24 $1.15 Million - $2.26 Million	60,652 Added 14.89%	468,078 $17.1 Million
Q3 2023 Nov 08, 2023	SELL	$23.12 - $31.38 $1.62 Million - $2.19 Million	-69,936 Reduced 14.65%	407,426 $9.42 Million
Q2 2023 Aug 09, 2023	SELL	$23.15 - $32.71 $103,642 - $146,442	-4,477 Reduced 0.93%	477,362 $12.5 Million
Q1 2023 May 10, 2023	BUY	$24.97 - $34.05 $1.49 Million - $2.03 Million	59,760 Added 14.16%	481,839 $12.4 Million
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $29,922 - $39,547	1,377 Added 0.33%	422,079 $11 Million
Q3 2022 Nov 09, 2022	BUY	$24.1 - $39.66 $674,920 - $1.11 Million	28,005 Added 7.13%	420,702 $12 Million
Q2 2022 Aug 09, 2022	SELL	$18.36 - $60.07 $55,814 - $182,612	-3,040 Reduced 0.77%	392,697 $9.67 Million
Q1 2022 May 11, 2022	BUY	$48.97 - $65.46 $540,237 - $722,154	11,032 Added 2.87%	395,737 $22.3 Million
Q4 2021 Feb 10, 2022	SELL	$53.3 - $75.84 $155,582 - $221,376	-2,919 Reduced 0.75%	384,705 $23.8 Million
Q3 2021 Nov 10, 2021	SELL	$62.66 - $88.26 $326,959 - $460,540	-5,218 Reduced 1.33%	387,624 $24.6 Million
Q2 2021 Aug 13, 2021	SELL	$67.45 - $85.63 $77,365 - $98,217	-1,147 Reduced 0.29%	392,842 $32.4 Million
Q1 2021 May 13, 2021	SELL	$65.1 - $93.59 $404,921 - $582,129	-6,220 Reduced 1.55%	393,989 $29 Million
Q4 2020 Feb 12, 2021	SELL	$48.36 - $77.92 $4.09 Million - $6.59 Million	-84,591 Reduced 17.45%	400,209 $29 Million
Q3 2020 Nov 12, 2020	SELL	$36.14 - $51.99 $430,535 - $619,356	-11,913 Reduced 2.4%	484,800 $23.1 Million
Q2 2020 Aug 11, 2020	BUY	$22.98 - $48.57 $863,312 - $1.82 Million	37,568 Added 8.18%	496,713 $20.9 Million
Q1 2020 May 14, 2020	BUY	$20.44 - $41.21 $894,781 - $1.8 Million	43,776 Added 10.54%	459,145 $12.4 Million
Q4 2019 Feb 13, 2020	BUY	$17.74 - $39.52 $950,810 - $2.12 Million	53,597 Added 14.82%	415,369 $16 Million
Q3 2019 Nov 05, 2019	BUY	$18.8 - $27.82 $6.8 Million - $10.1 Million	361,772 New	361,772 $7.84 Million

Others Institutions Holding SWTX

# of Institutions

221

Shares Held

66.8M

Call Options Held

64.7K

Put Options Held

150K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Spring Works Therapeutics, Inc. Transaction History